However, these studies highlight that epigenetic silencing by BET protein inhibitors promotes anti-tumor immunity and potentiates anti-tumor effect of immune checkpoint inhibitor in pancreatic cancer. This evidence concerns the gene DNER and pancreatic neoplasm.